146 filings
Page 5 of 8
8-K
4xa0v9uadh310 gf
29 Mar 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
tygm u89g4bjh1
27 Mar 18
Regulation FD Disclosure
12:00am
8-K
px0mjy537dgt4xjjfi0
26 Mar 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
mo8thu2u1at7o5klt51u
26 Mar 18
RXi Pharmaceuticals Reports Fourth Quarter and Year End 2017
12:00am
8-K
od5j4d9g3de68ddyt
24 Jan 18
Other Events
12:00am
8-K
yww2l6 s3
5 Jan 18
RXi Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
lmcqva0
8 Nov 17
RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
12:00am
8-K
7olta0qd16 jvdp
15 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
iesicmy no2l
10 Aug 17
RXi Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
12:00am
8-K
c6dv8m2g
9 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
pzkpgyrfs
3 Aug 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
j7urjtg5tk9jiz9v
9 Jun 17
Unregistered Sales of Equity Securities
12:00am
8-K
iegv37pmpst4nq7u79t
11 May 17
RXi Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Corporate Highlights
12:00am
8-K
auf1pwt9hyouvwg1e
1 May 17
Other Events
12:00am
8-K
54et7gkrwppat0xd
18 Apr 17
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
12:00am
8-K
nemk1
30 Mar 17
RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights
12:00am
8-K
6g56xj
29 Mar 17
Regulation FD Disclosure
12:00am
8-K
35egcsqa
28 Mar 17
Regulation FD Disclosure
12:00am
8-K
iwt52i i2tx53oruno
3 Feb 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
qf9sa
10 Jan 17
Entry into a Material Definitive Agreement
12:00am